Yu‐I Weng
Impact in
- Biochemistry top 10%
- Phytochemicals and Antioxidant Activities
-
- Epigenetics and DNA Methylation
- Protein Kinase Regulation and GTPase Signaling
- Peroxisome Proliferator-Activated Receptors
- Genomics, phytochemicals, and oxidative stress
- Receptor Mechanisms and Signaling
Papers in
-
- Epigenetics and DNA Methylation 4
- Protein Kinase Regulation and GTPase Signaling 2
- RNA modifications and cancer 2
- Histone Deacetylase Inhibitors Research 1
-
- Renin-Angiotensin System Studies 2
- Co-authors
- Shivendra D. Shukla (2 shared papers)Yuan‐Teh Lee (2 shared papers)Brent W. Krugh (2 shared papers)Gary A. Weisman (2 shared papers)Grace Y. Sun (2 shared papers)Jianfeng Xu (1 shared paper)Zhongji Liao (2 shared papers)Yi‐Wen Huang (3 shared papers)
- Journals
- European Journal of Pharmacology (2 papers)Journal of Neurochemistry (2 papers)Nutrition and Cancer (1 paper)The Prostate (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- United StatesTaiwanHong Kong
In The Last Decade
Yu‐I Weng
10 papers receiving 440 citations
Peers
Comparison fields: 5 of 70
- Biochemistry 47
- Molecular Biology 262
- Cancer Research 49
- Complementary and alternative medicine 26
- Biochemistry 22
Countries citing papers authored by Yu‐I Weng
This map shows the geographic impact of Yu‐I Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐I Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐I Weng more than expected).
Fields of papers citing papers by Yu‐I Weng
This network shows the impact of papers produced by Yu‐I Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐I Weng. The network helps show where Yu‐I Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐I Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 104 | |
| 2 | 2013 | 103 | |
| 3 | 1992 | 58 | |
| 4 | 2011 | 52 | |
| 5 | 2000 | 37 | |
| 6 | 1993 | 33 | |
| 7 | 2002 | 31 | |
| 8 | 2012 | 16 | |
| 9 | 2020 | 10 | |
| 10 | 2002 | 1 |
About Yu‐I Weng
Yu‐I Weng is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Physiology and Pathology and Forensic Medicine, having authored 10 papers that have together received 445 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (4 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Nitric Oxide and Endothelin Effects (2 papers), RNA modifications and cancer (2 papers), Renin-Angiotensin System Studies (2 papers), Phytochemistry and Biological Activities (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Biochemistry (47 citations), Molecular Biology (262 citations), Cancer Research (49 citations), Complementary and alternative medicine (26 citations) and Biochemistry (22 citations). Yu‐I Weng has collaborated with scholars based in United States, Taiwan and Hong Kong. Frequent co-authors include Shivendra D. Shukla, Yuan‐Teh Lee, Brent W. Krugh, Gary A. Weisman, Grace Y. Sun, Jianfeng Xu, Zhongji Liao, Yi‐Wen Huang, Tim H.‐M. Huang and Ming‐Chih Lee. Their work appears in journals such as European Journal of Pharmacology, Journal of Neurochemistry, Nutrition and Cancer, The Prostate and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.